The journey, step by step

Most international CAR-T programmes stop describing the process at the infusion. Very few can describe what happens next — and that is exactly where the difference is made.

Approximately six weeks in total — thirty of those days under close monitoring.

1
Step 1

Eligibility

Your medical file is reviewed by our council. This determines whether a CAR-T programme is suitable — and if it is not, we will say so clearly.

What to prepare

Epicrisis or physician summary • Pathology and bone marrow reports • Recent blood tests • PET/CT or MRI reports • List of current medications

2
Step 2

Leukapheresis

Your white blood cells are collected through a standard apheresis procedure, in the treatment centre or — where feasible — in your own country.

What to prepare

Recent complete blood count • Vascular access assessment • Infection screening — organised by the centre before the procedure

3
7–12 days

Manufacturing

Your cells are engineered into CAR-T cells in Türkiye's first EU-GMP certified CAR-T facility in Ankara, established with TÜSEB support, and released after full quality control.

What to prepare

No documents are required from you at this stage — your coordinator manages the schedule and keeps you informed.

4
Step 4

Conditioning

A short lymphodepleting chemotherapy prepares your body to receive the CAR-T cells.

What to prepare

Centre-specific instructions are shared by your coordinator before admission • Your current medication list

5
Day 0

Infusion

Your own engineered cells are returned to you in a single infusion — day zero of the new phase.

What to prepare

Signed informed consent forms • Written emergency-contact plan provided by the centre

6
Step 6

30-day monitoring

You stay close to the centre for thirty days — the window in which CRS and ICANS, the known side effects of CAR-T, are managed by the treating team.

What to prepare

Patient diary if given by the centre • Emergency contact numbers kept at hand

7
Step 7

Return + follow-up

After you return home, follow-up continues in your own country through our licensed home-care network, with data returned to your own physician.

What to prepare

Discharge summary and laboratory results • Agreed follow-up schedule • Contact details of your physician at home

Journey questions

Start with the documents listed under the eligibility assessment: a current epicrisis or physician summary, pathology reports, recent blood tests, imaging reports and your treatment history. Your coordinator confirms the final checklist for your specific situation before travel.

In most cases yes. The need for a companion is evaluated according to your clinical condition and the treatment team recommendation, and a support plan is especially important during the close monitoring period after infusion.

Fever, shortness of breath, chest pain, altered consciousness or rapid deterioration require emergency medical evaluation. The written plan given to you at the centre states exactly whom to call — keep those numbers at hand at all times during the monitoring window.

With your consent, written updates are shared with your referring physician at agreed intervals, and treatment data is returned in an agreed format so follow-up continues seamlessly in your country after you return home.

Your coordinator prepares the return with you: the follow-up schedule, laboratory monitoring plan, emergency criteria, and where applicable the coordination of home-care services with your own physician.

Most programmes end here

Steps six and seven are where the difference is made.

Our licensed home-care network carries the follow-up after discharge — the step that makes the last mile possible.

81

provinces

300+

nurses

95+

physicians